[Retracted] Rosiglitazone Suppresses the Growth and Invasiveness of SGC-7901 Gastric Cancer Cells and Angiogenesis In Vitro via PPARγ Dependent and Independent Mechanisms

Figure 3

(a) RGZ (1–20 𝜇M) inhibited the mRNA and (c) protein expression levels of MMP-2 in a dose-dependent manner, which were not affected by 2.5 𝜇M GW9662 pretreatment for 1 hour (b), (c). RGZ (1–20 𝜇M) did not change the expression of VEGF in SGC-7901 cells (a), (c).

(a)

(b)

(c)